BIIB Biogen Inc

Price (delayed)

$220.95

Market cap

$32.12B

P/E Ratio

27.55

Dividend/share

N/A

EPS

$8.02

Enterprise value

$38.41B

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. ...

Highlights
The equity has grown by 10% YoY and by 2.2% from the previous quarter
The company's quick ratio has shrunk by 57% YoY but it rose by 2.2% QoQ
Biogen's debt has increased by 11% YoY but it has decreased by 4.9% from the previous quarter
The P/E is 75% above the 5-year quarterly average of 15.7 and 28% above the last 4 quarters average of 21.5
Biogen's net income has shrunk by 62% YoY and by 21% QoQ

Key stats

What are the main financial stats of BIIB
Market
Shares outstanding
145.36M
Market cap
$32.12B
Enterprise value
$38.41B
Valuations
Price to book (P/B)
2.16
Price to sales (P/S)
3.25
EV/EBIT
29.62
EV/EBITDA
21.44
EV/Sales
3.9
Earnings
Revenue
$9.84B
EBIT
$1.3B
EBITDA
$1.79B
Free cash flow
$1.24B
Per share
EPS
$8.02
Free cash flow per share
$8.54
Book value per share
$102.14
Revenue per share
$67.97
TBVPS
$84.74
Balance sheet
Total assets
$26.84B
Total liabilities
$12.05B
Debt
$7.34B
Equity
$14.8B
Working capital
$3.43B
Liquidity
Debt to equity
0.5
Current ratio
2
Quick ratio
0.92
Net debt/EBITDA
3.51
Margins
EBITDA margin
18.2%
Gross margin
74.2%
Net margin
11.8%
Operating margin
13.2%
Efficiency
Return on assets
4.4%
Return on equity
8.1%
Return on invested capital
7.9%
Return on capital employed
5.5%
Return on sales
13.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BIIB stock price

How has the Biogen stock price performed over time
Intraday
1.82%
1 week
-1.06%
1 month
-10.85%
1 year
-18.83%
YTD
-14.62%
QTD
-14.62%

Financial performance

How have Biogen's revenue and profit performed over time
Revenue
$9.84B
Gross profit
$7.3B
Operating income
$1.3B
Net income
$1.16B
Gross margin
74.2%
Net margin
11.8%
BIIB's operating income has dropped by 64% year-on-year and by 19% since the previous quarter
Biogen's operating margin has plunged by 63% YoY and by 18% from the previous quarter
Biogen's net income has shrunk by 62% YoY and by 21% QoQ
Biogen's net margin has plunged by 61% YoY and by 19% from the previous quarter

Growth

What is Biogen's growth rate over time

Valuation

What is Biogen stock price valuation
P/E
27.55
P/B
2.16
P/S
3.25
EV/EBIT
29.62
EV/EBITDA
21.44
EV/Sales
3.9
The P/E is 75% above the 5-year quarterly average of 15.7 and 28% above the last 4 quarters average of 21.5
The EPS has plunged by 62% YoY and by 21% from the previous quarter
BIIB's price to book (P/B) is 36% lower than its 5-year quarterly average of 3.4 and 20% lower than its last 4 quarters average of 2.7
The equity has grown by 10% YoY and by 2.2% from the previous quarter
The stock's price to sales (P/S) is 17% less than its last 4 quarters average of 3.9 and 7% less than its 5-year quarterly average of 3.5
Biogen's revenue has decreased by 3.3% YoY

Efficiency

How efficient is Biogen business performance
The ROE has plunged by 67% YoY and by 22% from the previous quarter
Biogen's return on assets has shrunk by 65% YoY and by 23% QoQ
The ROIC has plunged by 64% YoY and by 17% from the previous quarter
The ROS has plunged by 64% YoY and by 18% from the previous quarter

Dividends

What is BIIB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BIIB.

Financial health

How did Biogen financials performed over time
The total assets is 123% more than the total liabilities
The company's quick ratio has shrunk by 57% YoY but it rose by 2.2% QoQ
The current ratio has contracted by 33% YoY but it has grown by 19% from the previous quarter
Biogen's debt is 50% less than its equity
Biogen's debt has increased by 11% YoY but it has decreased by 4.9% from the previous quarter
The equity has grown by 10% YoY and by 2.2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.